The OHDSI community prides itself on global collaboration through open science. As a virtual community with collaborators on six different continents, we have weekly meetings to present research, share information, and keep each other updated on both current and upcoming projects. We hold these meetings on Tuesdays at 11 am ET in our Microsoft Teams environment. If you don’t have access to this, please fill out this form.
You can learn about our weekly calls, including the upcoming schedule of topics, and see materials (videos/slides/shoutouts) from previous calls by visiting our Community Calls page.
OHDSI has a variety of ongoing projects led by workgroups. Each workgroup has its own leadership team which determines the project’s objectives, goals and artifacts to be contributed to the community. Workgroup participation is open to all who have an interest in contributing to the project objectives and goals. Workgroups may be long-standing, strategic objectives or short-term projects to accomplish a specific need in the community. Each of the workgroups has its own home in the Teams environment, and you can get access to these groups by filling out this form (please note that you must have Teams access first, which is available through the first form linked above).
Please use our Upcoming Workgroup Calls page to see the upcoming schedule of calls (and appropriate links), as well as the standard schedule of calls for each group (weekly, bi-weekly, monthly, etc.).
The weekly update is below. If you missed any previous updates, or are looking for links to past updates or presentations, they are stored on our weekly Community Calls page.
We hope you will bring your talents, interests, curiosity and enthusiasm to OHDSI by joining both our weekly community calls and the workgroups that most interest you. That is how you #JoinTheJourney.
WEEKLY UPDATE • May 17, 2022
Debate 1: Phenotype Development: One-size-fits-all vs. Tailored-per-databases
Debaters: Azza Shoaibi (Associate Director, Janssen Research & Development) and Asieh Golozar (VP, Global Head of Data Science, Odysseus Data Services, Inc.)
Debate 2: Study Diagnostics: Nice-to-have vs. Essential requirements
Debaters: Dani Prieto-Alhambra (Professor, Univ. of Oxford and Erasmus Univ.) and Martijn Schuemie (Research Fellow, Epidemiology Analytics, Janssen Research & Development
• Congratulations to the team of Justin Reese, Ben Coleman, Lauren Chan, Hannah Blau, Tiffany J. Callahan, Luca Cappelletti, Tommaso Fontana, Katie R. Bradwell, Nomi L. Harris, Elena Casiraghi, Giorgio Valentini, Guy Karlebach, Rachel Deer, Julie A. McMurry, Melissa A. Haendel, Christopher G. Chute, Emily Pfaff, Richard Moffitt, Heidi Spratt, Jasvinder A. Singh, Christopher J. Mungall, Andrew E. Williams & Peter N. Robinson on the publication of NSAID use and clinical outcomes in COVID-19 patients: a 38-center retrospective cohort study in Virology Journal.
• Congratulations to the team of Edward Burn, Talita Duarte-Salles, Sergio Fernandez-Bertolin, Carlen Reyes, Kristin Kostka, Antonella Delmestri, Peter Rijnbeek, Katia Verhamme, and Daniel Prieto-Alhambra on the publication of Venous or arterial thrombosis and deaths among COVID-19 cases: a European network cohort study in The Lancet Infectious Diseases.
• The next CDM Workshop will be held inside MS Teams this Thursday, May 19 (1 pm ET), and it will focus on ETL Vocabulary Mapping. If you are interested in taking part, please fill out this form.
• The Roux Institute will host a one-day Symposium on Risks and Opportunities of AI in Clinical Drug Development on June 6. The event will be held in Portland, Maine, though you can attend this event virtually as well. The event, sponsored by Pfizer Inc., Northeastern University, the American Statistical Association (ASA), the Statistics Department and Data Science Institute at Columbia University, and OHDSI, is designed to serve as a platform for distinguished statisticians, data scientists, regulators, and other professionals to address the challenges and opportunities of AI in pharmaceutical medicine; to foster collaboration among industry, academia, regulatory agencies, and professional associations; and to propose recommendations with policy implications for proper implementation of AI in promoting public health.
• EHDEN is now hosting its sixth open call for data partners looking to map their patient data to the OMOP CDM. Through its first five open calls, EHDEN has created a federated data network of 140 partners across 26 countries, and it has also trained and certified 47 SMEs to assist with mapping this data. Data Partners can benefit from up to a maximum of €100 000 funding. The deadline to apply is June 14, 2022.
• All the talks and workshops from DevCon 2022 have now been uploaded to the DevCon homepage on OHDSI.org.
• Want to help provide the foundation for future advances in OHDSI global research, and receive some benefits for your company in return? Check out the OHDSI Sponsorship homepage, which includes the community call presentation from George Hripcsak.
2022 OHDSI Symposium
• Registration has opened for the 2022 OHDSI Symposium, which will be held Oct. 14-16 at the Bethesda North Marriott Hotel & Conference Center. The main conference will be held Friday, Oct. 14, while a full-day tutorial (An Introductory Journey from Data to Evidence) will be held Saturday, Oct. 15. There will be several workgroup activities between Oct. 15-16 as well. Here are several important links for #OHDSI2022.
2022 OHDSI European Symposium
• The 2022 OHDSI European Symposium, which will be held at the Steam Ship Rotterdam in The Netherlands, will be held June 24-26. The main symposium will be June 24, and tutorials will be held June 25-26. For more information and the registration link, please visit the symposium homepage.
Debate 1: Phenotype Development: One-size-fits-all vs. Tailored-per-databases (Shoaibi vs. Golozar)
Debate 2: Study Diagnostics: Nice-to-have vs. Essential requirements (Schuemie vs. Prieto-Alhambra)